ACS Stirs Discord By Placing Its Own Logo On A Coalition’s Petition, Then Reconsiders
In Brief: Hohn Named President, CEO Of Roswell Park; Mendelsohn Honored; AACE Elects Officers
IOM Appoints 17 To National Cancer Policy Board
Patient Advocacy: FDA, NCI Developing Methods For Naming Survivors To Boards
Regulatory Agencies: FDA Proposes “Treatment IDE” Funding Opportunities:
Nominations Sought For Women’s Health Achievement AwardsFor Medical Devices
Trending Stories
- The Directors: Tom Lynch and Skip Burris on how NIH funding cuts imperil biopharma innovation—and cost patient lives
In a time of uncertainty, “react to the knowns, not the fear” - As cancer scientists, we must change how we engage with the public on the impact of NIH cuts
What the scientific method obscures - In weekly vigils, current and former NIH staff grieve the impact of Trump cuts
The Saturday gatherings at NIH’s Metro station are part graveside service, part street theater - She flew Black Hawks and battled cancer—now Col. Susan Fondy grapples with cuts to lymphedema research
- Scaling excellence: How City of Hope is transforming cancer care delivery
- First-ever financial toxicity tumor board aims to change the standard of care
Researchers focus on debt as a side effect of cancer, treatment amid cuts to Medicaid, NCI
